Skip to content
Longevity RankedSource-based provider review

Source-based provider review

MyDrHank review: NAD+, sermorelin and the $137 starting price.

MyDrHank advertises separate NAD+ and sermorelin programs from $137 per month on its selected product landings. That is a starting rate: the pages say the prescribed protocol and dose determine the final price. NAD+ is offered as a nasal spray or subcutaneous injection, without a clear price-to-format or quantity breakdown. Both pages advertise a free first consultation and shipping, but neither establishes a complete first bill or refill schedule. MyDrHank's terms say its pharmacy list is available on request and that prescribing is discretionary. This review separates the two offers, their unresolved payment details and the location rules affecting our partner links. It evaluates public information, not treatment results or a personal prescription.

Prices at a glance · checked September 29, 2026

This review covers NAD+ and sermorelin shopping. For other care, use HRT Picks' TRT comparisons or GLP-1 Picks' weight-loss comparisons. Prices and findings do not transfer across treatment lines.

Who should take a closer look?

Worth investigating if a clinician-led, cash-pay assessment and a visible starting price match your shopping priorities, provided you obtain the actual product and billing quote.

What should give you pause?

The same starting figure appears on different products. It does not prove the same supplied quantity, route, monitoring or ongoing cost.

This is a review of public product and contract information, not a hands-on medical test. No paid ranking or patient testimonial. We may earn a commission if you buy through our MyDrHank partner link. This does not change our findings, score or comparison order. Review method.

What does MyDrHank offer, and what does it cost?

NAD+ · Nasal spray or subcutaneous injection

Compounded NAD+ care

Advertised
$137From $137 per month; prescribed protocol and dose determine price
Initial plan amount
Not verifiedExact selected bill not verified
Recurring payment
Exact charge and schedule not verified

The exact product landing advertises a from-$137 monthly starting price, not a complete bill or verified renewal. It does not tie every available format, strength or supplied quantity to that starting amount.

Explore MyDrHank NAD+

Sermorelin · Prescribed route not established by the captured offer

Compounded Sermorelin care

Advertised
$137From $137 per month; prescribed protocol and dose determine price
Initial plan amount
Not verifiedExact selected bill not verified
Recurring payment
Exact charge and schedule not verified

The exact product landing advertises a from-$137 monthly starting price, not a complete bill or verified renewal. It does not tie every available format, strength or supplied quantity to that starting amount.

Explore MyDrHank Sermorelin

Both exact landings say from $137 per month and qualify the price by prescribed protocol and dose. They advertise a free first consultation and free delivery, but do not establish when medication is charged, the full initial commitment, the next invoice or whether later laboratory work has a separate fee. No insurance billing is offered. A no-bloodwork-to-start statement does not define an appropriate monitoring plan.

Prices are USD, checked September 29, 2026. These are advertised self-pay offers, not a personalized quote or an assurance of insurance coverage. The full medication quantity and mandatory fees are not conclusively joined to every price.

Public-information score

How is MyDrHank's public information scored?

5/10

We score the information a shopper can reasonably check before enrolling: product, payments, care, pharmacy and cancellation. This is an editorial disclosure score, not a clinical-quality, safety or patient-outcome rating. Full credit means the disclosure meets our check; it does not mean the treatment is right for you.

Scope: NAD+ and Sermorelin offers covered in this review. Assessed ; underlying source review . Read the scoring rules.

Five scores and their sources

Product detail1/2

Partial. NAD+ routes are described, but a usable sermorelin formulation and quantity breakdown is not established.

Selected MyDrHank NAD+ offer and delivery FAQ · Selected MyDrHank sermorelin offer

Price and payment1/2

Partial. Starting prices are qualified by the selected protocol; first and recurring charges remain unknown.

Selected MyDrHank NAD+ offer and delivery FAQ · Selected MyDrHank sermorelin offer

Care process1/2

Partial. Clinical assessment is described, but the reviewed longevity offer does not explain an ongoing clinical contact or follow-up service.

Terms of Use: operator, pharmacy and prescribing

Pharmacy disclosure1/2

Partial. The reviewed terms describe US-licensed pharmacy partners and a list available on request. No named network or assignment explanation is established in this source set.

Terms of Use: operator, pharmacy and prescribing

Cancellation and refunds1/2

Partial. Cancel-anytime language is visible, but the reviewed terms do not establish a prescription refund schedule or processing cutoff.

Selected MyDrHank NAD+ offer and delivery FAQ · Selected MyDrHank sermorelin offer · Terms of Use: operator, pharmacy and prescribing

Does $137 buy the same product in both MyDrHank offers?

No such equivalence is established. The NAD+ landing includes nasal spray and subcutaneous injection, while the sermorelin landing concerns a different molecule. Each qualifies its starting price by the clinician's selected protocol and dose. The captured sermorelin offer does not supply a usable formulation, concentration and quantity breakdown.

Request the exact route, quantity, full charge and refill schedule for the prescription offered to you. The published from-price is useful for starting that conversation; it cannot support a cost-per-equivalent-treatment ranking.

Do MyDrHank's marketing promises establish expected results?

The landings market energy, sleep, recovery and body-composition improvements. This source review does not establish those outcomes for a particular patient or the products supplied. The same pages also disclose compounded status and acknowledge limitations. A marketing claim is not a substitute for product-specific human evidence.

Ask the clinician what evidence supports the proposed use, what risks and monitoring apply, and how they would judge whether continuing treatment is appropriate. Our NAD+ and sermorelin evidence guides distinguish biological mechanisms from demonstrated outcomes.

What does MyDrHank publish clearly?

  • Separate NAD+ and sermorelin landings each qualify the from-$137 price by the prescribed protocol.
  • The NAD+ page identifies nasal and subcutaneous routes instead of presenting one unnamed format.
  • Product disclosures identify the preparations as compounded and not FDA-approved.

These are observable disclosures, not a certification of the provider.

Is MyDrHank legit, and which pharmacy is involved?

A binary “legit” badge would overstate this review. We verified the listed public offer and policies, not every professional license, shipment, laboratory claim or customer outcome. The clinical service, prescribing clinician, pharmacy and medication each deserve their own checks.

Dr. Hank, LLC identifies itself as the website operator in the Terms of Use. Those terms describe US-licensed pharmacy partners and say a current list is available on request. We have not established which pharmacy or clinician would be assigned to an NAD+ or sermorelin order. Ask for their names and contact details before prescription fulfillment.

The product pages say treatment is available in selected US states without enumerating a product-specific list. Separately, our partner offer excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia. That advertising restriction is not a clinical eligibility determination. Our location step keeps an ordinary provider link available for excluded or unspecified locations.

Is MyDrHank's treatment FDA-approved or guaranteed safe?

FDA approval applies to a particular drug product and indication, not to a provider's entire business. The compounded products discussed in this review are not FDA-approved. FDA does not review compounded drugs before marketing in the way it reviews approved medicines. FDA: risks of compounded drugs

Historical approval of Geref does not approve a current compounded sermorelin formulation for longevity. A published price or a named pharmacy is not a substitute for an individual clinical assessment. FDA: discontinued Geref determination (2013)

How do cancellation and refunds work at MyDrHank?

Both product landings advertise cancellation at any time. The Terms of Use reviewed do not provide a medication refund schedule, prescription-processing cutoff or rule for an unused prepaid balance. Obtain the cancellation deadline and refund policy for the selected order in writing; ending a subscription does not necessarily undo services or medication already provided.

Ask for the next processing date and save the policy attached to your order. Ending a subscription and getting a refund are separate questions, especially once a prescription has reached the pharmacy.

What should I confirm before submitting an order?

  1. Which route, strength and supplied quantity does the quoted amount purchase?
  2. What are the first payment, next bill, billing interval and required monitoring costs?
  3. Which clinician and pharmacy serve this product in your state?
  4. What happens to your payment if declined or if you cancel after pharmacy processing?

Use those questions to resolve gaps in the public record, not to choose a dose. Our payment explorer can show the financial schedule only when the published inputs support it.

Which original sources support this review?

The following official product and policy pages were checked on September 29, 2026. Public text may change, and checkout-specific conditions still need confirmation. If you find a mismatch, send a correction with the page and source.

These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.

Which alternatives should I compare with MyDrHank?

Compare the same molecule and route before deciding a different headline is better value. Other NAD+ injection providers in our source audit are AgelessRx, Embody, Luvo Health, Pallas Health, PeterMD, RNK Health, SHED, Sprout Health, System Labs, Wellorithm, Willow. Each still has its own fees, contract and clinical-assessment questions.

For sermorelin injections, compare AgelessRx, Embody, Luvo Health, Pallas Health, PeterMD, RNK Health, System Labs, Wellorithm in the sermorelin provider guide and check the cheapest published sermorelin payments and renewal terms.